TY - JOUR
T1 - Updating Urinary Microbiome Analyses to Enhance Biologic Interpretation
AU - Siddiqui, Nazema Y.
AU - Ma, Li
AU - Brubaker, Linda
AU - Mao, Jialiang
AU - Hoffman, Carter
AU - Dahl, Erin M.
AU - Wang, Zhuoqun
AU - Karstens, Lisa
N1 - Funding Information:
We would like to graciously acknowledge the women who provided clinical samples as part of the HMS-ESTEEM study, the participating sites from the Pelvic Floor Disorders Network (PFDN), as well as Yuko Komesu, Darrell Dinwiddie, and the University of New Mexico Clinical & Translational Science Center where primary sequencing data were generated. We would also like to acknowledge Ben Carper, Carolyn Huitema and Marie Gantz from RTI International (Research Triangle Park, NC), members of the PFDN Data Coordinating Center who assisted with data transfer and public data sharing. Finally, we acknowledge Karstens laboratory members from Oregon Health & Science University, Jean-Philippe Gourdine and Alec Barstad, for assistance with data processing.
Publisher Copyright:
Copyright © 2022 Siddiqui, Ma, Brubaker, Mao, Hoffman, Dahl, Wang and Karstens.
PY - 2022/7/8
Y1 - 2022/7/8
N2 - Objective: An approach for assessing the urinary microbiome is 16S rRNA gene sequencing, where analysis methods are rapidly evolving. This re-analysis of an existing dataset aimed to determine whether updated bioinformatic and statistical techniques affect clinical inferences. Methods: A prior study compared the urinary microbiome in 123 women with mixed urinary incontinence (MUI) and 84 controls. We obtained unprocessed sequencing data from multiple variable regions, processed operational taxonomic unit (OTU) tables from the original analysis, and de-identified clinical data. We re-processed sequencing data with DADA2 to generate amplicon sequence variant (ASV) tables. Taxa from ASV tables were compared to the original OTU tables; taxa from different variable regions after updated processing were also compared. Bayesian graphical compositional regression (BGCR) was used to test for associations between microbial compositions and clinical phenotypes (e.g., MUI versus control) while adjusting for clinical covariates. Several techniques were used to cluster samples into microbial communities. Multivariable regression was used to test for associations between microbial communities and MUI, again while adjusting for potentially confounding variables. Results: Of taxa identified through updated bioinformatic processing, only 40% were identified originally, though taxa identified through both methods represented >99% of the sequencing data in terms of relative abundance. Different 16S rRNA gene regions resulted in different recovered taxa. With BGCR analysis, there was a low (33.7%) probability of an association between overall microbial compositions and clinical phenotype. However, when microbial data are clustered into bacterial communities, we confirmed that bacterial communities are associated with MUI. Contrary to the originally published analysis, we did not identify different associations by age group, which may be due to the incorporation of different covariates in statistical models. Conclusions: Updated bioinformatic processing techniques recover different taxa compared to earlier techniques, though most of these differences exist in low abundance taxa that occupy a small proportion of the overall microbiome. While overall microbial compositions are not associated with MUI, we confirmed associations between certain communities of bacteria and MUI. Incorporation of several covariates that are associated with the urinary microbiome improved inferences when assessing for associations between bacterial communities and MUI in multivariable models.
AB - Objective: An approach for assessing the urinary microbiome is 16S rRNA gene sequencing, where analysis methods are rapidly evolving. This re-analysis of an existing dataset aimed to determine whether updated bioinformatic and statistical techniques affect clinical inferences. Methods: A prior study compared the urinary microbiome in 123 women with mixed urinary incontinence (MUI) and 84 controls. We obtained unprocessed sequencing data from multiple variable regions, processed operational taxonomic unit (OTU) tables from the original analysis, and de-identified clinical data. We re-processed sequencing data with DADA2 to generate amplicon sequence variant (ASV) tables. Taxa from ASV tables were compared to the original OTU tables; taxa from different variable regions after updated processing were also compared. Bayesian graphical compositional regression (BGCR) was used to test for associations between microbial compositions and clinical phenotypes (e.g., MUI versus control) while adjusting for clinical covariates. Several techniques were used to cluster samples into microbial communities. Multivariable regression was used to test for associations between microbial communities and MUI, again while adjusting for potentially confounding variables. Results: Of taxa identified through updated bioinformatic processing, only 40% were identified originally, though taxa identified through both methods represented >99% of the sequencing data in terms of relative abundance. Different 16S rRNA gene regions resulted in different recovered taxa. With BGCR analysis, there was a low (33.7%) probability of an association between overall microbial compositions and clinical phenotype. However, when microbial data are clustered into bacterial communities, we confirmed that bacterial communities are associated with MUI. Contrary to the originally published analysis, we did not identify different associations by age group, which may be due to the incorporation of different covariates in statistical models. Conclusions: Updated bioinformatic processing techniques recover different taxa compared to earlier techniques, though most of these differences exist in low abundance taxa that occupy a small proportion of the overall microbiome. While overall microbial compositions are not associated with MUI, we confirmed associations between certain communities of bacteria and MUI. Incorporation of several covariates that are associated with the urinary microbiome improved inferences when assessing for associations between bacterial communities and MUI in multivariable models.
KW - bioinformatic analysis
KW - bladder dysfunction
KW - lactobacilli
KW - microbiota
KW - mixed urinary incontinence
KW - urinary microbiome
KW - urobiome
UR - http://www.scopus.com/inward/record.url?scp=85134659732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134659732&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2022.789439
DO - 10.3389/fcimb.2022.789439
M3 - Article
C2 - 35899056
AN - SCOPUS:85134659732
SN - 2235-2988
VL - 12
JO - Frontiers in cellular and infection microbiology
JF - Frontiers in cellular and infection microbiology
M1 - 789439
ER -